85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05515627 (ClinicalTrials.gov)	February 15, 2023	12/8/2022	Atezolizumab for Idiopathic Pulmonary Fibrosis	A Phase I Study to Evaluate the Safety and Preliminary Efficacy of Atezolizumabin Idiopathic Pulmona ...	Idiopathic Pulmonary Fibrosis	Drug: Atezolizumab	Cedars-Sinai Medical Center	Genentech, Inc.	Recruiting	50 Years	80 Years	All	24	Phase 1	United States
2	JPRN-jRCTs031190084	05/09/2019	27/08/2019	TORG1936 / AMBITIOUS study	A phase II study of Atezolizumabfor advanced / recurrent Non-Small Cell Lung Cancer with Idiopathic ...	Advanced / recurrent Non-small cell lung cancer with idiopathic interstitial pneumonia	Atezolizumab 1200mg, every 3 weeks	KATO Terufumi	IKEDA Satoshi	Complete	>= 20age old	Not applicable	Both	38	Phase 2	Japan

First Previous1Next Last